News | News By Subject | News by Disease News By Date | Search News

Urinary tract infection/Cystitis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Sophiris Bio (SPHS) Phase III BPH Study Successfully Meets Primary Endpoint     11/10/2015
TetraPhase (TTPH) Sinks 80% Premarket as Eravacycline Fails to Meet Phase III Trial Goals     9/10/2015
Allergan (AGN) Shows Off Positive Data from AVYCAZ Phase III Study     9/2/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Cubist Pharmaceuticals, Inc. (CBST)'s Urinary Tract Infection Drug Succeeds In Phase 3 Study     11/27/2013
NovaBay Pharmaceuticals, Inc. (NBY)'s Auriclosene Cuts Down Blockages in Catheters in Phase 2 Trial     9/16/2013
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic     10/8/2012
Endo Pharmaceuticals (ENDP) to Buy HealthTronics (HTRN) for $223 Million     5/6/2010
Ranbaxy Laboratories (RANBAXY.BO) Unable to Launch New Generic, Flomax; Shares Fall     3/3/2010
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Commences Phase I Human Clinical Trial for the Prevention of Catheter Associated Urinary Tract Infections     3/7/2008
Ortho-McNeil, Inc. Says Gets FDA Approval for Doribax     10/15/2007
FDA Approves Ortho-McNeil Pharmaceutical, Inc.'s LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis     9/17/2007
Q-Med Scandinavia Inc. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux     8/7/2007
Depomed, Inc. (DEPO) Reaquires Rights to ProQuin XR     7/5/2007

News from Around the Web
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
This Man Is Addressing UTI In Indian Women With A Smart Device     1/30/2017
Using Garlic To Fight UTIs, Universiti Putra Malaysia Study     7/13/2015
Your Diet Could Be Causing Your UTIs, Washington University in St. Louis Study     7/6/2015
Antibiotic Appears More Effective Than Cranberry Capsules for Preventing Urinary Tract Infections, Academic Medical Center, Amsterdam Study     7/27/2011
New Treatment for Urinary Tract Infections Called Promising, University of Miami Study     4/18/2011
Urinary Tract Infections Becoming Harder to Treat, University of Hong Kong Researchers Find     5/18/2010
UTI Vaccine Shows Early Promise, University of Michigan Study     9/21/2009
Oral Antibiotics Effective to Treat Severe Urinary Tract Infections     10/17/2007
Antibiotics Don't Prevent Future Urinary Tract Infections, May Cause Resistance in Future Infections, Children's Hospital of Philadelphia Study     7/16/2007
Treatments For Urinary infections Leave Bacteria Bald, Happy And Vulnerable     12/21/2006
Compounds In Cranberry Juice Show Promise As Alternatives To Antibiotics     9/11/2006
Bacterium That Causes Kidney Stones And Complicated Urinary Tract Infections Gives Up Its Genetic Secrets     5/25/2006
Cranberry Juice Prevents Cavities?     11/23/2005
Viagra Improves Urinary Tract Symptoms In Men With Erectile Dysfunction     11/21/2005

Press Releases
Zavante Therapeutics Presents Positive Results From NIH-Sponsored ZOLYD Phase I Trial At ASM Microbe 2017 Meeting     6/5/2017
Forge Therapeutics And Evotec AG (EVTG.F) Present First Efficacy Data For LpxC Inhibitor In UTI Model At ASM Microbe 2017     6/5/2017
Hennepin Life Sciences Presents Pre-Clinical Data Showing Anti-Microbial Activity Of Glycerol Monolaurate In Preventing And Treating Catheter-Associated Urinary Tract Infections     6/5/2017
Pixie Scientific Announces The FDA Registration And U.S. Commercial Launch Of Its Smart Pads For Monitoring Urinary Tract Infections (Utis) In Incontinent Seniors     5/3/2017
Zavante Therapeutics' ZOLYD Met Primary Endpoint In Pivotal ZEUS Study For Treatment Of Complicated Urinary Tract Infections     4/6/2017
Zavante Therapeutics Release: Company Reports Completion Of Patient Treatment In The ZEUS Study Of ZTI-01 (fosfomycin for injection) For The Treatment Of Complicated Urinary Tract Infections     1/19/2017
TetraPhase (TTPH) Doses First Patient In IGNITE3 Phase III Clinical Trial Of Once-Daily IV Eravacycline In cUTI     1/17/2017
Shionogi Release: Pharma Announces Positive Top-Line Results For Cefiderocol Pivotal cUTI Clinical Trial     1/12/2017
Duchesnay Release: Company Is Pleased To Announce That Health Canada Has Granted Market Authorization For Mictoryl/Mictoryl Pediatric     1/10/2017
Iterum Announces Sulopenem In Development For Treatment Of Gram-Negative, Multi-Drug Resistant Infections     1/5/2017
TetraPhase (TTPH) Provides Regulatory And Clinical Update For Eravacycline     12/19/2016
Fimbrion And GlaxoSmithKline (GSK) To Develop Novel Antibacterial Therapy For Urinary Tract Infections     10/25/2016
Allergan (AGN) Release: FDA Accepts Supplemental New Drug Application (sNDA) For AVYCAZ (Ceftazidime And Avibactam)     10/11/2016
Enteris Biopharma Initiates Clinical Program For Tobrate (Oral Tobramycin Tablet) In Uncomplicated Urinary Tract Infection     7/13/2016
Zavante Therapeutics Enrolls First Patient In The ZEUS Study For ZTI-01 For The Treatment Of Complicated Urinary Tract Infections     7/11/2016